Your Article Summary
See Latest ArticlesEffect of Nonergot Dopamine Agonists on Symptoms of Restless Legs Syndrome
Annals of Family Medicine, 05/13/08
Baker WL et al. - Use of NEDAs in patients with moderate-to-severe restless legs syndrome results in significant reductions in symptom severity, but a significant portion of patients will discontinue their use as a result of adverse events.
Related Articles
Review: Improving symptom control in early Parkinson's disease
Therapeutic Advances in Neurological Disorders, 11/23/09
Relevance Score: 87%
Novel targets in pain research: The case for CB2 receptors as a biorational pain target
Current Anaesthesia and Critical Care, 11/24/09
Relevance Score: 83%
Dopamine agonist-induced antecollis in Parkinsons disease
Movement Disorders, 11/18/09
Relevance Score: 83%
Inhibition of specific adenylyl cyclase isoforms by lithium and carbamazepine, but not valproate, may be related to their antidepressant effect
Bipolar Disorders, 11/24/09
Relevance Score: 82%
A novel toll-like receptor 9 agonist cooperates with trastuzumab in trastuzumab-resistant breast tumors through multiple mechanisms of action
Clinical Cancer Research, 11/18/09
Relevance Score: 81%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Optimizing conventional therapies for inflammatory bowel disease
Current Gastroenterology Reports, 12/07/09
Linezolid in the Treatment of Multidrug-Resistant Tuberculosis
Clinical Infectious Diseases, 12/07/09
Review: erythropoiesis-stimulating agents increase mortality in patients with cancer
Evidence-Based Medicine, 12/07/09